Mirazimi Y, Aghayan A, Atashi A, Mohammadi D, Rafiee M
Ann Hematol. 2025; .
PMID: 40087154
DOI: 10.1007/s00277-025-06300-6.
Leung J, Chiu H, Taneja R
Br J Cancer. 2025; .
PMID: 40055485
DOI: 10.1038/s41416-025-02961-2.
Lin Y, Wang Y, Li L, Zhang K
Genes Dis. 2025; 12(3):101347.
PMID: 40034125
PMC: 11875173.
DOI: 10.1016/j.gendis.2024.101347.
Gong L, Zou C, Zhang H, Yang F, Qi G, Ma Z
Genes (Basel). 2025; 16(2).
PMID: 40004471
PMC: 11855738.
DOI: 10.3390/genes16020140.
Habara A
Cells. 2025; 14(4).
PMID: 39996784
PMC: 11854342.
DOI: 10.3390/cells14040312.
circAFF2 promotes the development of AML by binding to PML mRNA.
Yao L, Zhang X, Li X, Xu J, Yang S, Li F
Oncogene. 2025; .
PMID: 39930271
DOI: 10.1038/s41388-025-03299-y.
Circular RNAs in cancer.
Guo Y, Huang Q, Heng Y, Zhou Y, Chen H, Xu C
MedComm (2020). 2025; 6(2):e70079.
PMID: 39901896
PMC: 11788016.
DOI: 10.1002/mco2.70079.
Circular RNA promoted tumorigenesis and osimertinib resistance in lung adenocarcinoma via a circular RNA-microRNA network.
Hao Z, Feng F, Wang Q, Wang Y, Li J, Huang J
J Thorac Dis. 2025; 16(12):8754-8770.
PMID: 39831223
PMC: 11740053.
DOI: 10.21037/jtd-2024-2144.
CircZMYM2 Alleviates TGF-β1-Induced Proliferation, Migration and Activation of Fibroblasts via Targeting miR-199b-5p/KLF13 Axis.
Han Y, Zhao J, Liao X, Wang R, Dong L
Appl Biochem Biotechnol. 2025; .
PMID: 39808406
DOI: 10.1007/s12010-024-05168-y.
The therapeutic potential of circular RNAs.
OLeary E, Jiang Y, Kristensen L, Hansen T, Kjems J
Nat Rev Genet. 2025; .
PMID: 39789148
DOI: 10.1038/s41576-024-00806-x.
New Axes of Interaction in Circ_0079593/miR-516b-5p Network in Melanoma Metastasis Cell Lines.
De Tomi E, Orlandi E, Belpinati F, Patuzzo C, Trabetti E, Gomez-Lira M
Genes (Basel). 2025; 15(12.
PMID: 39766913
PMC: 11675925.
DOI: 10.3390/genes15121647.
Circular RNAs in cancer: roles, mechanisms, and therapeutic potential across colorectal, gastric, liver, and lung carcinomas.
Malviya A, Bhuyan R
Discov Oncol. 2025; 16(1):5.
PMID: 39755870
PMC: 11700081.
DOI: 10.1007/s12672-025-01743-9.
Circular RNAs as a novel class of potential therapeutic and diagnostic biomarkers in reproductive biology/diseases.
Song W, Chen X, Wu H, Rahimian N
Eur J Med Res. 2024; 29(1):643.
PMID: 39741306
PMC: 11689626.
DOI: 10.1186/s40001-024-02230-7.
The Diagnostic Value of circFBXW7, circABCB10, and circ0103552 Levels in Breast Cancer.
Ilhan B, Ender S, Kilic B, Ucuncu M, Serilmez M, Tilgen Yasasever C
Curr Issues Mol Biol. 2024; 46(12):14381-14393.
PMID: 39727990
PMC: 11674701.
DOI: 10.3390/cimb46120862.
Circular RNA CDR1as/ciRS-7- a novel biomarker in solid tumors.
Zhang Y, Xiong C, Jiang Z, Wang X, Ji J, Pan Y
Front Oncol. 2024; 14:1468363.
PMID: 39678511
PMC: 11638042.
DOI: 10.3389/fonc.2024.1468363.
Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?.
Zou J, Xu B, Luo P, Chen T, Duan H
Front Immunol. 2024; 15:1482765.
PMID: 39628486
PMC: 11611751.
DOI: 10.3389/fimmu.2024.1482765.
Hsa_circRNA_000166 accelerates breast cancer progression via the regulation of the miR-326/ELK1 and miR-330-5p/ELK1 axes.
Wang M, Liu Z, Zhang H, Liu H, Ma L
Ann Med. 2024; 56(1):2424515.
PMID: 39529543
PMC: 11559033.
DOI: 10.1080/07853890.2024.2424515.
Circular RNA circABCC4 as the ceRNA facilitates renal carcinoma progression.
Yao Y, Wang T, Li S, Song Q, Yuan K
World J Urol. 2024; 42(1):607.
PMID: 39475972
DOI: 10.1007/s00345-024-05279-5.
Recent Progress of CircRNAs in Hematological Malignancies.
Cui Y, Wang L, Xu J, Nan H, Yang P, Niu J
Int J Med Sci. 2024; 21(13):2544-2561.
PMID: 39439468
PMC: 11492881.
DOI: 10.7150/ijms.98156.
TRMT10C-mediated m7G modification of circFAM126A inhibits lung cancer growth by regulating cellular glycolysis.
Zhao Q, Li X, Wu J, Zhang R, Chen S, Cai D
Cell Biol Toxicol. 2024; 40(1):78.
PMID: 39289194
PMC: 11408563.
DOI: 10.1007/s10565-024-09918-w.